Navigation Links
FDA's Grace McNally to Appear at ISPE Facilities Conference
Date:2/8/2012

TAMPA, Fla., Feb. 8, 2012 /PRNewswire-USNewswire/ -- ISPE announced today that the US FDA's Grace McNally will appear at the Society's upcoming Lessons from 483s: Enhancing Efficiency, Quality and cGMP Compliance Conference. McNally will add her expertise to that of other industry and regulatory experts at the two-day event, which will review recent regulatory citations (FDA-483s) and provide guidance on how the citations can be avoided. This conference will give pharmaceutical professionals the vital insights into regulatory issues they need in order to avoid the costly and damaging consequences that can result from 483 citations, such as recalls and plant shutdowns.

(Logo: http://photos.prnewswire.com/prnh/20120208/DC49497LOGO)

Educational content will address 483s in the context of biotech, oral solid dosage processing and containment, and process validation. The conference, part of ISPE's Facilities of the Future conference series, will take place in Tampa, Florida USA on 27 – 28 February 2012.

"As the technical voice of manufacturing and engineering in the pharmaceutical industry, ISPE is committed to presenting programs that facilitate relevant dialogue and the sharing of best practices among industry leaders, manufacturing experts and leading regulators," said ISPE's new President and CEO Nancy Berg. "At a time when manufacturing operations are under tremendous pressures to improve effectiveness, deliver quality and reduce costs, ISPE is responding with new programs and conference formats that feature dynamic and focused session content. Our events are developed to deliver information, discussion and networking that lead to new ideas, problem-solving and process improvement concepts that, when applied, have positive bottom-line results."

The event will feature three keynote presentations from experts in the pharmaceutical industry and contain three topical information tracks.

For more information on this conference, including detailed agendas and registration information, visit www.ISPE.org/FacilitiesConference.

ISPE will also hold a related training course immediately following this conference. The course, titled "Managing the Risk of Cross Contamination: Applying the Risk-MaPP Baseline® Guide" will be held 29 February – 1 March 2012 at the same venue. More information on this training course can be found at www.ISPE.org/2012-Tampa-Training.

About ISPE

CONTACT: Danielle Hould, ISPE, 813-960-2105 x 277, dhould@ispe.org; Chris Mercier, Coles Marketing Communications, 317-571-0051 x106, mercier@colesmarketing.com

 

 


'/>"/>
SOURCE ISPE
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DMC Sinai-Grace Selects Loopback Communications Readmission Reduction™ Services
2. AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. Provide Medicines to Missouris Uninsured
3. Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS
4. "7th Heaven" and "Game Time" Star Catherine Hicks to Appear at the National Community Pharmacists Associations Convention October 10, 2011 in Nashville for Education Effort to Help Prevent Prescription Medication Abuse
5. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
6. Gloria Gaynor to Appear at AARPs Orlando@50+ National Event & Expo
7. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
8. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
9. Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin
10. Elbow Ligament Reconstruction Appears Not to Affect Future Professional Advancement in Baseball
11. Pharmaceutics International, Inc. (Pii) Announces cGMP Aseptic Facilities Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):